Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

66 results about "Trimethyl chitosan" patented technology

Trimethyl chitosan-graft-polyethylene glycol/nucleic acid brain-targeting micellar and preparation method thereof

The invention belongs to the technical field of medicine, and relates to an acetylcholine-receptor-mediated trimethyl chitosan-graft-polyethylene glycol / nucleic acid brain-targeting micellar and a preparation method thereof. According to the invention, trimethyl chitosan-graft-polyethylene glycol-brain-targeting functional peptide is obtained through the steps that: chitosan is sequentially subjected to quaternary ammonium modification such that trimethyl chitosan is obtained; the amino group of trimethyl chitosan is subjected to a reaction with an active group of two-end-activated polyethylene glycol, such that trimethyl chitosan-graft-polyethylene glycol is obtained; and another active group of polyethylene glycol is subjected to a reaction with brain-targeting functional peptide RVG. According to the invention, ion composite micellar is adopted as a carrier, and brain-targeting functional peptide RVG is adopted as a targeting molecule, such that nucleic acid medicine can actively target and position through blood-brain barrier and brain. The ion composite micellar provided by the invention is formed through static composition of positively charged trimethyl chitosan-graft-polyethylene glycol-brain-targeting functional peptide and negatively charged nucleic acid. With the invention, nucleic acid medicine defects such as easy in-vivo degradation, poor stability, and low transfection efficiency are solved.
Owner:SHENYANG PHARMA UNIVERSITY

Preparation method and application of fatty acid-trimethyl chitosan polymer modified by lactobionic acid

The invention discloses a fatty acid-trimethyl chitosan polymer modified by a lactobionic acid, a preparation method and an application. The fatty acid-trimethyl chitosan polymer modified by the lactobionic acid is an active targeting nano micelle carrier material. A trimethyl chitosan with a good water-solubility is used as a carrier material, the hydrophobic modification is performed by a fatty acid, and then the surface modification is performed by the lactobionic acid to obtain a polymer micelle with the lactobionic acid which mediates tumor tissue target. Harmine is used as a model drug to prepare a drug-loaded nano-micelle in a rubbing and self-assembly mode. A test confirms that the drug loading capacity and encapsulated ratio of the drug-loaded nano-micelle are high, the slow-release property is achieved, cells are effectively taken in through a lactobionic acid receptor pathway, and distribution of drugs on the tumor tissue is increased, so that the curative effect is improved, the toxic and side effect is reduced, and targeted therapy is achieved. The fatty acid-trimethyl chitosan polymer modified by the lactobionic acid, the preparation method and the application provide an ideal novel drug carrier and a preparation form for antitumor drugs with slightly solubility.
Owner:SUZHOU UNIV

O-alpha-methyl mandelate-N-trimethyl chitosan quaternary ammonium salt as well as preparation method and application thereof

The invention belongs to the field of high molecular compound materials and discloses a chitosan-chemically modified functional derivative, namely O-alpha-methyl mandelate-N-trimethyl chitosan quaternary ammonium salt as well as a preparation method and application thereof. The preparation method of the O-alpha-methyl mandelate-N-trimethyl chitosan quaternary ammonium salt comprises the following steps: taking chitosan, formaldehyde and formic acid as starting materials, carrying out microwave reaction to obtain chitosan schiff base, and then carrying out reaction with iodomethane to obtain N,N,N-trimethyl chitosan; and dissolving N,N,N-trimethyl chitosan with methane sulfonic acid, and then adding O-alpha-formyl mandelate acyl chloride into the mixed solution for reacting so as to obtain the O-alpha-methyl mandelate-N-trimethyl chitosan quaternary ammonium salt. The O-alpha-methyl mandelate-N-trimethyl chitosan quaternary ammonium salt has good water solubility, has greatly increased antibacterial properties compared with the chitosan raw material and N,N,N-trimethyl chitosan, and can be applied to many application fields of antibacterial medical materials, chemical products for daily use, food packages and the like.
Owner:HUNAN UNIV OF TECH

Preparation method of supermolecule globular micelle based on antidepressant medicament chlorpromazine

The invention discloses a preparation method of a supermolecule globular micelle based on an antidepressant medicament chlorpromazine. The method comprises the following steps: constructing a medicament carrier through the supermolecule interaction of amphiphilic sulfonated calix [4] arene and an antidepressant medicament chlorpromazine hydrochloride, dissolving the amphiphilic sulfonated calix [4] arene and the antidepressant medicament chlorpromazine hydrochloride in water, and uniformly mixing to obtain a nano supermolecule globular micelle solution; and non-covalently modifying a targeting agent trimethyl chitosan through a bonding site of the calix arene on the surface of the micelle to obtain the supermolecule micelle loaded with trimethyl chitosan on the surface. The preparation method has the advantages that the preparation method is simple and convenient, and fewer subjective and objective raw materials are used; the medicament load rate is high since the medicament molecules are the constructing units of the medicament carrier and the medicament molecules are immobilized; the micelle can be used for non-covalently modifying the targeting agent trimethyl chitosan through the bonding site of the surface calix arene so that the micelle has a wide application prospect in the field of targeted medicament delivery.
Owner:NANKAI UNIV

Sustained release drug delivery system

The invention discloses a controlled release dosage form comprising a therapeutically effective amount of a pharmaceutically active agent, illustrated by Acyclovir, that would release in about 12 hours not more than about 90% of the said active agent in a simulated gastric juice in a first order rate of release in a USP type 1 dissolution test, and not containing a solubilizer or a swelling enhancer or both, comprising (a) a tablet made from polymer matrix of at least two biocompatible polymers, illustrated by Carbopol 974P and polyethylene oxide, the said pharmaceutically active agent and pharmaceutically permitted excipients; the said tablet capable of rapid swelling without disintegration in the said simulated gastric juice to a size that shall result in its gastric retention in the stomach and start controlled release of the said active agent by starting controlled erosion as well as diffusion immediately after coming into contact with the said gastric juice, or (b) microspheres of ungrafted chitosan or a chitosan derivative illustrated by thiolated chitosan and trimethyl chitosan, or Carbopol incorporating the said active agent, wherein the said pharmaceutically active agent is not a polymeric molecule and after administration in stomach, the said microspheres adhare to the gastric mucosa for a long time releasing the active agent in a controlled way.
Owner:BIOPLUS LIFE SCI PVT

Base fertilizer for water chestnut planting field

The invention discloses base fertilizer for a water chestnut planting field. The base fertilizer is characterized by being prepared from the following raw materials in percentage by mass: 28 percent to 32 percent of composted cattle pen manure, 8 percent to 12 percent of phosphorus fertilizer, 2 percent to 4 percent of zinc-boron fertilizer, 28 percent to 32 percent of plant ash, 20 percent to 24 percent of oilseed cake and 4 percent to 6 percent of an auxiliary material. The auxiliary material comprises the following components in parts by weight: 14 to 20 parts of modified bamboo powder, 4 to 8 parts of vermiculite powder, 5 to 9 parts of sepiolite powder, 2 to 4 parts of sodium humate, 2 to 4 parts of straw powder and 3 to 5 parts of turf. The modified bamboo powder is prepared by adopting the following process: stirring N,N,N-trimethyl chitosan, glacial acetic acid and water; dropwise adding a silver nitrate solution under a stirring state; then dropwise adding a sodium borohydride solution and stirring to obtain a prefabricated material; stirring gelatin and the water; adding sodium hydroxide and stirring; adjusting the pH (Potential of Hydrogen) value to be 7.1 to 7.5; adding succinic anhydride and stirring; drying and crushing; adding a silane coupling agent, the bamboo powder, the prefabricated material and toluene; raising the temperature, stirring, washing, drying and crushing to obtain the modified bamboo powder.
Owner:无为县年香马蹄种植专业合作社

O-thiazolidine methyl ester-N-trimethyl chitosan quaternary ammonium salt as well as preparation method and application thereof

The invention belongs to the field of the high polymer compound materials and discloses an O-thiazolidine methyl ester-N-trimethyl chitosan quaternary ammonium salt as well as a preparation method and application thereof. The preparation method of the O-thiazolidine methyl ester-N-trimethyl chitosan quaternary ammonium salt comprises the following steps: carrying out a microwave reaction on starting raw materials (including chitosan, formaldehyde and formic acid) to obtain a chitosan Schiff base and then reacting the chitosan Schiff base with methyl iodide to obtain N-trimethyl chitosan; preparing thiazolidine formyl chloride by using L-thiazolidine-4-formic acid and thionyl chloride, adding the thiazolidine formyl chloride to N-trimethyl chitosan to obtain the O-thiazolidine methyl ester-N-trimethyl chitosan quaternary ammonium salt. The O-thiazolidine methyl ester-N-trimethyl chitosan quaternary ammonium salt is greatly improved in term of antibacterial property in contrast with the chitosan, and thus can be applied to various fields such as antibacterial materials, chemical products of daily use and industrial wastewater treatment.
Owner:SOUTH CHINA UNIV OF TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products